Cargando…
Author Correction: Insulin-producing organoids engineered from islet and amniotic epithelial cells to treat diabetes
Autores principales: | Lebreton, Fanny, Lavallard, Vanessa, Bellofatto, Kevin, Bonnet, Romain, Wassmer, Charles H., Perez, Lisa, Kalandadze, Vakhtang, Follenzi, Antonia, Boulvain, Michel, Kerr-Conte, Julie, Goodman, David J., Bosco, Domenico, Berney, Thierry, Berishvili, Ekaterine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7547092/ https://www.ncbi.nlm.nih.gov/pubmed/33037230 http://dx.doi.org/10.1038/s41467-020-19127-8 |
Ejemplares similares
-
Insulin-producing organoids engineered from islet and amniotic epithelial cells to treat diabetes
por: Lebreton, Fanny, et al.
Publicado: (2019) -
Generation of insulin‐secreting organoids: a step toward engineering and transplanting the bioartificial pancreas
por: Wassmer, Charles‐Henri, et al.
Publicado: (2020) -
Biosynthetic Activity Differs Between Islet Cell Types and in Beta Cells Is Modulated by Glucose and Not by Secretion
por: Cottet-Dumoulin, David, et al.
Publicado: (2020) -
Bio-Engineering of Pre-Vascularized Islet Organoids for the Treatment of Type 1 Diabetes
por: Wassmer, Charles-Henri, et al.
Publicado: (2022) -
NLRP3 Inflammasome is Activated in Rat Pancreatic Islets by Transplantation and Hypoxia
por: Lavallard, Vanessa, et al.
Publicado: (2020)